Ivan M Robbins, M.D.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge. Agrawal V, D'Alto M, Naeije R, Romeo E, Xu M, Assad TR, Robbins IM, Newman JH, Pugh ME, Hemnes AR, Brittain EL (2019) J Am Heart Assoc 8(17): e012504
   › Primary publication · 31475602 (PubMed) · PMC6755835 (PubMed Central)
2. Pulmonary Edema After Initiation of Parenteral Prostaglandin Therapy: More Common Than We Think but How Clinically Important Is It? Robbins IM (2019) Chest 156(1): 7-8
   › Primary publication · 31279377 (PubMed)
3. Human PAH is characterized by a pattern of lipid-related insulin resistance. Hemnes AR, Luther JM, Rhodes CJ, Burgess JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday SJ, Hekmat R, Howard L, Newman JH, Niswender KD, Pugh ME, Robbins IM, Sheng Q, Shibao CA, Shyr Y, Sumner S, Talati M, Wharton J, Wilkins MR, Ye F, Yu C, West J, Brittain EL (2019) JCI Insight 4(1)
   › Primary publication · 30626738 (PubMed) · PMC6485674 (PubMed Central)
4. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR, UK NIHR BioResource Rare Diseases Consortium, UK PAH Cohort Study Consortium, US PAH Biobank Consortium (2019) Lancet Respir Med 7(3): 227-238
   › Primary publication · 30527956 (PubMed) · PMC6391516 (PubMed Central)
5. Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension. Halliday SJ, Xu M, Thayer TE, Mosley JD, Sheng Q, Ye F, Farber-Eger EH, Pugh ME, Robbins IR, Assad TR, West JD, Brittain EL, Hemnes AR (2018) Pulm Circ 8(4): 2045894018800544
   › Primary publication · 30142026 (PubMed) · PMC6134494 (PubMed Central)
6. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X, Fessel JP, Fike CD, Fong P, Fortune N, Gerszten RE, Johnson JA, Kaplowitz M, Newman JH, Piana R, Pugh ME, Rice TW, Robbins IM, Wheeler L, Yu C, Loyd JE, West J (2018) Eur Respir J 51(6)
   › Primary publication · 29903860 (PubMed) · PMC6613216 (PubMed Central)
7. The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Meoli DF, Su YR, Brittain EL, Robbins IM, Hemnes AR, Monahan K (2018) Pulm Circ 8(1): 2045893217745019
   › Primary publication · 29251543 (PubMed) · PMC5764145 (PubMed Central)
8. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL (2017) JAMA Cardiol 2(12): 1361-1368
   › Primary publication · 29071338 (PubMed) · PMC5814998 (PubMed Central)
9. End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension. Welch CE, Brittain EL, Newman AL, Robbins IM, Pugh ME, Newman JH, Hemnes AR (2017) Ann Am Thorac Soc 14(6): 896-902
   › Primary publication · 28345964 (PubMed) · PMC6850742 (PubMed Central)
10. Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension. Assad TR, Brittain EL, Wells QS, Farber-Eger EH, Halliday SJ, Doss LN, Xu M, Wang L, Harrell FE, Yu C, Robbins IM, Newman JH, Hemnes AR (2016) Pulm Circ 6(3): 313-21
    › Primary publication · 27683608 (PubMed) · PMC5019084 (PubMed Central)
11. Update on chronic thromboembolic pulmonary hypertension. Robbins IM, Pugh ME, Hemnes AR (2017) Trends Cardiovasc Med 27(1): 29-37
    › Primary publication · 27345156 (PubMed)
12. Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomy. Matthews DT, Le CN, Robbins IM, Petracek MR, Pugh ME, Brittain EL, Hemnes AR (2016) Pulm Circ 6(2): 174-80
    › Primary publication · 27252843 (PubMed) · PMC4869921 (PubMed Central)
13. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, Zhao Z, Gaskill C, Jetter C, Kropski JA, Majka SM, Austin ED (2016) Am J Respir Crit Care Med 194(4): 464-75
    › Primary publication · 26926454 (PubMed) · PMC5003329 (PubMed Central)
14. Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction. Mar PL, Nwazue V, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Loyd JE, Hemnes AR, Robbins IM, Robertson D, Raj SR, Austin ED (2016) Chest 149(5): 1252-60
    › Primary publication · 26836906 (PubMed) · PMC4944774 (PubMed Central)
15. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study. Hay BR, Pugh ME, Robbins IM, Hemnes AR (2016) Chest 149(3): 660-6
    › Primary publication · 26378379 (PubMed) · PMC4944766 (PubMed Central)
16. Response to Letter Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease". Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA (2015) Circulation 132(2): e17
    › Primary publication · 26169652 (PubMed) · PMC4624330 (PubMed Central)
17. Translocation of Microspheres into the Pulmonary Artery after Bronchial Artery Injection. Robbins IM, Johnson J, Petracek M, Lambright E, Bream P, Merantz S, Pugh ME, Hemnes AR (2015) Am J Respir Crit Care Med 191(12): e28-9
    › Primary publication · 26075434 (PubMed) · PMC5442967 (PubMed Central)
18. Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Trammell AW, Pugh ME, Newman JH, Hemnes AR, Robbins IM (2015) Pulm Circ 5(2): 356-63
    › Primary publication · 26064462 (PubMed) · PMC4449248 (PubMed Central)
19. Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers. Pugh ME, Hemnes AR, Trammell A, Newman JH, Robbins IM (2014) Pulm Circ 4(4): 679-84
    › Primary publication · 25610603 (PubMed) · PMC4278627 (PubMed Central)
20. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders. Halliday SJ, Hemnes AR, Robbins IM, Pugh ME, Zhao DX, Piana RN, Fong PP, Brittain EL (2015) J Heart Lung Transplant 34(3): 312-8
    › Primary publication · 25577565 (PubMed) · PMC4380573 (PubMed Central)
21. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Shaver CM, Castilho JL, Cohen DN, Grogan EL, Miller GG, Dummer JS, Gray JN, Lambright ES, Loyd JE, Robbins IM (2014) Am J Transplant 14(12): 2893-7
    › Primary publication · 25376207 (PubMed) · PMC4263480 (PubMed Central)
22. Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J (2015) Circulation 131(4): 401-9; discussion 409
    › Primary publication · 25361553 (PubMed) · PMC4308423 (PubMed Central)
23. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Newman JH, Brittain EL, Robbins IM, Hemnes AR (2015) Chest 147(4): 1080-1085
    › Primary publication · 25340330 (PubMed) · PMC4388116 (PubMed Central)
24. ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease. Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA (2014) Circulation 130(14): 1179-91
    › Primary publication · 25062690 (PubMed) · PMC4182129 (PubMed Central)
25. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Benson L, Brittain EL, Pugh ME, Austin ED, Fox K, Wheeler L, Robbins IM, Hemnes AR (2014) Pulm Circ 4(2): 311-8
    › Primary publication · 25006450 (PubMed) · PMC4070784 (PubMed Central)
26. Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Larkin EK, Austin ED, Hemnes AR (2013) Pulm Circ 3(3): 589-98
    › Primary publication · 24618543 (PubMed) · PMC4070798 (PubMed Central)
27. Causes of pulmonary hypertension in the elderly. Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR (2014) Chest 146(1): 159-166
    › Primary publication · 24480915 (PubMed) · PMC4077408 (PubMed Central)
28. Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study. Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V (2014) Am Heart J 167(2): 218-225.e1
    › Primary publication · 24439983 (PubMed)
29. Updated clinical classification of pulmonary hypertension. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) J Am Coll Cardiol 62(25 Suppl): D34-41
    › Primary publication · 24355639 (PubMed)
30. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH (2014) Circ Heart Fail 7(1): 116-22
    › Primary publication · 24297689 (PubMed) · PMC3934572 (PubMed Central)
31. Combination therapy in pulmonary arterial hypertension. Pugh ME, Hemnes AR, Robbins IM (2013) Clin Chest Med 34(4): 841-55
    › Primary publication · 24267308 (PubMed)
32. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG (2014) Chest 145(2): 231-236
    › Primary publication · 24135949 (PubMed) · PMC3921094 (PubMed Central)
33. Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension. Brittain EL, Pugh ME, Wang L, Newman AL, Robbins IM, Newman JH, Hemnes AR (2013) PLoS One 8(10): e76461
    › Primary publication · 24124561 (PubMed) · PMC3790694 (PubMed Central)
34. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR (2013) JACC Heart Fail 1(4): 300-307
    › Primary publication · 24015376 (PubMed) · PMC3763862 (PubMed Central)
35. Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension. Monahan K, Scott TA, Su YR, Lenneman CG, Zhao DX, Robbins IM, Hemnes AR (2013) Pulm Circ 3(2): 345-9
    › Primary publication · 24015334 (PubMed) · PMC3757828 (PubMed Central)
36. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA, Hamid R, Loyd JE (2012) Am J Respir Crit Care Med 186(9): 892-6
    › Primary publication · 22923661 (PubMed) · PMC3530218 (PubMed Central)
37. Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR (2012) Chest 142(6): 1391-1398
    › Primary publication · 22576635 (PubMed) · PMC3515022 (PubMed Central)
38. National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease. Robbins IM, Moore TM, Blaisdell CJ, Abman SH (2012) Circulation 125(17): 2165-70
    › Primary publication · 22388326 (PubMed)
39. Improving outcomes for pulmonary vascular disease. Robbins IM, Moore TM, Blaisdell CJ, Abman SH (2012) Am J Respir Crit Care Med 185(9): 1015-20
    › Primary publication · 22335936 (PubMed) · PMC3359939 (PubMed Central)
40. Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Austin ED, Menon S, Hemnes AR, Robinson LR, Talati M, Fox KL, Cogan JD, Hamid R, Hedges LK, Robbins I, Lane K, Newman JH, Loyd JE, West J (2011) Pulm Circ 1(3): 389-98
    › Primary publication · 22140629 (PubMed) · PMC3224431 (PubMed Central)
41. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH (2011) Chest 140(5): 1267-1273
    › Primary publication · 21622547 (PubMed) · PMC4694178 (PubMed Central)
42. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR (2011) J Heart Lung Transplant 30(8): 904-11
    › Primary publication · 21493097 (PubMed) · PMC3129440 (PubMed Central)
43. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Luo YF, Robbins IM, Karatas M, Brixey AG, Rice TW, Light RW (2011) Chest 140(1): 42-47
    › Primary publication · 21212140 (PubMed)
44. Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR (2011) Exp Lung Res 37(1): 26-34
    › Primary publication · 21077779 (PubMed)
45. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO (2010) Respir Med 104(3): 454-62
    › Primary publication · 19880300 (PubMed) · PMC2826574 (PubMed Central)
46. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Austin ED, Phillips JA, Cogan JD, Hamid R, Yu C, Stanton KC, Phillips CA, Wheeler LA, Robbins IM, Newman JH, Loyd JE (2009) Respir Res : 87
    › Primary publication · 19785764 (PubMed) · PMC2762975 (PubMed Central)
47. Congenital pulmonary artery stenoses masquerading as chronic thromboembolic disease. Hemnes AR, Doyle TP, Janssen D, Robbins IM (2009) J Heart Lung Transplant 28(10): 1110-1
    › Primary publication · 19782296 (PubMed) · PMC2757639 (PubMed Central)
48. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Tang KJ, Robbins IM, Light RW (2009) Chest 136(3): 688-693
    › Primary publication · 19395582 (PubMed)
49. Association of the metabolic syndrome with pulmonary venous hypertension. Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW (2009) Chest 136(1): 31-36
    › Primary publication · 19188551 (PubMed) · PMC2716716 (PubMed Central)
50. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Hemnes AR, Robbins IM (2009) Liver Transpl 15(1): 15-9
    › Primary publication · 19109843 (PubMed) · PMC3804427 (PubMed Central)
51. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM (2007) J Heart Lung Transplant 26(4): 363-9
    › Primary publication · 17403478 (PubMed)
52. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA, Loyd JE, Nichols WC (2006) Am J Respir Crit Care Med 174(5): 590-8
    › Primary publication · 16728714 (PubMed) · PMC2648061 (PubMed Central)
53. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, Loscalzo J, Kimmel SE, Christman BW, Barst RJ (2006) Eur Respir J 27(3): 578-84
    › Primary publication · 16507859 (PubMed)
54. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA (2006) Am J Respir Crit Care Med 173(7): 798-802
    › Primary publication · 16339917 (PubMed) · PMC2662954 (PubMed Central)
55. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Cogan JD, Vnencak-Jones CL, Phillips JA, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE (2005) Genet Med 7(3): 169-74
    › Primary publication · 15775752 (PubMed)
56. Oxidant stress but not thromboxane decreases with epoprostenol therapy. Robbins IM, Morrow JD, Christman BW (2005) Free Radic Biol Med 38(5): 568-74
    › Primary publication · 15683712 (PubMed)
57. Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol. Kuhn KP, Wickersham NE, Robbins IM, Byrne DW (2004) Exp Lung Res 30(2): 135-45
    › Primary publication · 14972773 (PubMed)
58. Miliary tuberculosis as a cause of acute empyema. Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP (2003) Respiration 70(5): 529-32
    › Primary publication · 14665781 (PubMed)
59. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA (2003) Am J Respir Crit Care Med 167(6): 889-94
    › Primary publication · 12446270 (PubMed)
60. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM (2003) Am J Respir Crit Care Med 167(4): 580-6
    › Primary publication · 12446266 (PubMed)
61. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW (2001) Chest 120(5): 1639-44
    › Primary publication · 11713147 (PubMed)
62. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Doyle TP, Loyd JE, Robbins IM (2001) Am J Respir Crit Care Med 164(4): 657-60
    › Primary publication · 11520733 (PubMed)
63. Iatrogenic paradoxical air embolism in pulmonary hypertension. Holcomb BW, Loyd JE, Byrd BF, Wilsdorf TT, Casey-Cato T, Mason WR, Robbins IM (2001) Chest 119(5): 1602-5
    › Primary publication · 11348976 (PubMed)
64. Pulmonary veno-occlusive disease: a case series and new observations. Holcomb BW, Loyd JE, Ely EW, Johnson J, Robbins IM (2000) Chest 118(6): 1671-9
    › Primary publication · 11115457 (PubMed)
65. An interesting electrolyte problem. Sadikot RT, Robbins IM (2000) Postgrad Med J 76(897): 435, 447-8
    › Primary publication · 10878216 (PubMed) · PMC1741634 (PubMed Central)
66. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE (2000) Chest 117(1): 14-8
    › Primary publication · 10631192 (PubMed)
67. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension. Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE (1998) Chest 114(5): 1269-75
    › Primary publication · 9824000 (PubMed)
68. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, Kay GN (1998) Circulation 98(17): 1769-75
    › Primary publication · 9788832 (PubMed)
69. Angiotensin II mediates systemic rebound hypertension after cessation of prostacyclin infusion in sheep. Robbins IM, Cuiper LL, Stein CM, Wood AJ, He HB, Parker R, Christman BW (1998) J Appl Physiol (1985) 85(2): 731-7
    › Primary publication · 9688753 (PubMed)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword